Profit and Loss Results Results Snapshot
Figures in Cr
Consolidated - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
No of Months
12
12
12
12
12
12
Operating Income
623.00
580.00
510.00
472.00
424.00
386.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
623.00
580.00
510.00
472.00
424.00
386.00
Expenditure (Ex Depriciation)
Stock Adjustments
8.00
-5.00
-4.00
-13.00
3.00
-8.00
Raw Materials Consumed
282.00
284.00
245.00
232.00
193.00
191.00
Power & Fuel Cost
11.00
11.00
10.00
8.00
7.00
8.00
Employee Cost
112.00
102.00
93.00
79.00
63.00
58.00
Operating Expenses
27.00
23.00
18.00
16.00
15.00
16.00
General and Administration Expenses
-1.00
-1.00
-1.00
-1.00
-1.00
-1.00
Selling and Distribution Expenses
28.00
23.00
18.00
16.00
24.00
26.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
3.00
3.00
2.00
2.00
1.00
3.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
521.00
480.00
421.00
376.00
337.00
320.00
Operating Profit (PBDIT) excl Other Income
101.00
99.00
89.00
95.00
87.00
65.00
Other Income
22.00
34.00
22.00
9.00
5.00
11.00
Operating Profit (PBDIT)
123.00
134.00
111.00
105.00
92.00
76.00
Interest
1.00
1.00
2.00
1.00
1.00
2.00
Profit before Depriciation and Tax
122.00
132.00
109.00
104.00
91.00
74.00
Depreciation
12.00
10.00
9.00
8.00
7.00
7.00
Profit Before Taxation & Exceptional Items
109.00
122.00
100.00
95.00
83.00
67.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
109.00
122.00
100.00
95.00
83.00
67.00
Provision for Tax
26.00
28.00
27.00
26.00
21.00
15.00
Profit After Tax
82.00
93.00
72.00
69.00
62.00
51.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
507.00
417.00
348.00
282.00
220.00
176.00
Profit Available for appropriations
589.00
510.00
421.00
351.00
282.00
227.00
Appropriations
589.00
510.00
421.00
351.00
282.00
227.00
Equity Dividend (%)
18.00%
18.00%
15.00%
15.00%
15.00%
15.00%
Earnings Per Share
41.11
46.58
36.40
34.63
31.08
25.72
Profit And Loss Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2025 is 7.35% vs 13.76% in Mar 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2025 is 1.59% vs 12.00% in Mar 2024
Interest
YoY Growth in year ended Mar 2025 is 28.53% vs -27.84% in Mar 2024
Profit After Tax
YoY Growth in year ended Mar 2025 is -11.74% vs 27.99% in Mar 2024
Compare Profit and Loss Results of Lincoln Pharma.
Figures in Cr
consolidated - Profit And Loss Results
Change(INR)
Change(%)
No of Months
12
12
Operating Income
623.00
647.00
-24.00
-3.71%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
623.00
647.00
-24.00
-3.71%
Expenditure (Ex Depriciation)
Stock Adjustments
8.00
4.00
4.00
100.00%
Raw Materials Consumed
282.00
373.00
-91.00
-24.40%
Power & Fuel Cost
11.00
6.00
5.00
83.33%
Employee Cost
112.00
80.00
32.00
40.00%
Operating Expenses
27.00
17.00
10.00
58.82%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
28.00
60.00
-32.00
-53.33%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
3.00
0.00
3.00
0%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
521.00
584.00
-63.00
-10.79%
Operating Profit (PBDIT) excl Other Income
101.00
63.00
38.00
60.32%
Other Income
22.00
20.00
2.00
10.00%
Operating Profit (PBDIT)
123.00
84.00
39.00
46.43%
Interest
1.00
0.00
1.00
0%
Profit before Depriciation and Tax
122.00
84.00
38.00
45.24%
Depreciation
12.00
22.00
-10.00
-45.45%
Profit Before Taxation & Exceptional Items
109.00
61.00
48.00
78.69%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
109.00
71.00
38.00
53.52%
Provision for Tax
26.00
26.00
0.00
0.00%
Profit After Tax
82.00
45.00
37.00
82.22%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
507.00
170.00
337.00
198.24%
Profit Available for appropriations
589.00
215.00
374.00
173.95%
Appropriations
589.00
215.00
374.00
173.95%
Equity Dividend (%)
18%
0%
18.00
Earnings Per Share
41.11
33.9
7.21
21.27%
Profit And Loss - Net Sales
Net Sales 623.23 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 7.35% vs 13.76% in Mar 2024
Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 101.49 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 1.59% vs 12.00% in Mar 2024
Profit And Loss - Interest
Interest 1.88 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 28.53% vs -27.84% in Mar 2024
Profit And Loss - Profit After Tax
Profit After Tax 82.35 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -11.74% vs 27.99% in Mar 2024
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
